CorrigendumIn the article by Eldred-Evans [1], the AUC value in paragraph 3 was incorrect in the original published version; it should have been 0.85. This has been corrected in the online version.The correct paragraph reads as follows:The results are encouraging, with upgrading occurring in only 1.8% of men with a prior negative MRI. With follow-up, progression to radical treatment was 12.8%, which is consistent with the established diagnostic performance of mpMRI. The authors seek further improvements by investigating if PSA dynamics can identify men with a negative MRI at risk of progression. They find that PSA velocity is strongly associated with subsequent progression (AUC 0.85, P < 0.001) and conclude that men on AS with low-risk disease can safely avoid biopsy in favour of MRI, PSA monitoring and selective re-biopsy.
Reference1 Eldred-Evans D, Ahmed HU. Re-thinking active surveillance for the multiparametric magnetic resonance imaging era.